Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk

CompletedOBSERVATIONAL
Enrollment

634,939

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

November 16, 2022

Study Completion Date

August 18, 2025

Conditions
Stimulant Overdose
Interventions
OTHER

Aim 1 (case-cohort study)

"* Cases: All Medicaid enrollees age 15 years or older with at least one inpatient hospitalization or emergency department visit indicating a stimulant overdose during 2016-2020~* Subcohort: A random sample of all Medicaid enrollees age 15 years or older irrespective of their stimulant overdose history during 2016-2020"

OTHER

Aim 2 (case-crossover study)

"* Case period: 60 days before the date of stimulant overdose through the day before the date of stimulant overdose~* Control period: 179 days before the date of stimulant overdose through 120 days before the date of stimulant overdose~* Washout period: 119 days before the date of stimulant overdose through 61 days before the date of stimulant overdose"

OTHER

Aim 3 (cohort study)

All Medicaid enrollees age 15 years or older with at least one inpatient hospitalization or emergency department visit indicating a stimulant overdose during 2016-2020

Trial Locations (1)

19104

UNIVERSITY OF PENNSYLVANIA Perelman SCHOOLS OF MEDICINE, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT05976984 - Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk | Biotech Hunter | Biotech Hunter